LRMR Insider Trading
Insider Ownership Percentage: 3.50%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00
Larimar Therapeutics Insider Trading History Chart
This chart shows the insider buying and selling history at Larimar Therapeutics by year and by quarter.
Skip ChartChart Data in Insider Trading History Table
Larimar Therapeutics Share Price & Price History
Current Price: $2.00
Price Change: ▼ Price Decrease of -0.15 (-6.98%)
As of 04/1/2025 05:00 PM ET
Larimar Therapeutics Insider Trading History
Larimar Therapeutics Institutional Trading History
Data available starting January 2016
Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal genetic disease. Larimar Therapeutics, Inc. is based in Bala Cynwyd, Pennsylvania.
Read More on Larimar Therapeutics
Volume
927,899 shs
Average Volume
647,751 shs
Market Capitalization
$128.06 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.99
Who are the company insiders with the largest holdings of Larimar Therapeutics?